Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Infographic: Blood Screening & Blood Transfusions
“The United States is the biggest user of blood transfusions—approximately 5 million people in the U.S. receive blood and blood components through 10.9 million transfusions per year.” – Kalorama Information The global $2.5 billion blood screening market is evolving on many levels, and despite it’s maturity the industry is poised for growth through 2026 […]
Coagulation Tests Near 4 Billion, Per IVD Newsletter
The 2021 global market for coagulation tests (lab-based and all POC) neared 4 billion last year. PT and d-dimer tests lead revenues, per Kalorama’s In Vitro Diagnostic Business Outlook. The publication focuses on one aspect of the IVD market in each issue. The publication comes out 2 times a month. This issue focused on […]
8 Recent Developments in Cell and Gene Therapy
There have been a number of recent developments in cell and gene therapy, as detailed in our bi monthly newsletter, Cell and Gene Therapy Business Outlook. New approvals in various countries, and technology licenses. Bristol-Myers Squibb K.K., a Tokyo-based subsidiary of Bristol-Myers Squibb (BMS), has announced that Japan’s Ministry of Health, Labour and Welfare has […]
Digital Pathology Gets Big
The global digital pathology market is valued at $866 million in 2021, consisting of hardware, software and related services for clinical applications. In 2020, markets experienced slowing demand early in the year due to reduced orders and budget freezes as the COVID-19 pandemic surged on over the year. The impact began to soften in the […]
Viral Vectors Market Reaches $712 Million as Gene Therapy and COVID-19 Vaccines Create Growth
The total viral vector market sported revenues of $712.2 million in 2021, according to research published in Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities, a new report by leading medical market researcher Kalorama Information. Viral vectors are altered viruses that can safely transport therapeutic products into cells and growth is forecast […]
This Week in Cell and Gene Therapy: 12 Recent Developments
The following are a dozen developments in the cell and gene therapy market from Volume 1, Issue 14 of Cell and Gene Therapy Business Outlook, published January 10, 2022. Allogene Therapeutics, based South San Francisco, CA, has announced that the Food and Drug Administration has cleared the company to resume clinical trials its CAR-T […]
Global Liquid Biopsy Market to Exceed $3 Billion by 2026 with Focus on Cancer and Oncology
There are over 40 companies active in the $1 billion global market for liquid biopsy diagnostics and monitoring tests. And demand is growing swiftly, at a projected compound annual growth rate (CAGR) of 29.5% over the next five years, as patients, clinicians, and payors increasingly accept liquid biopsy as an alternative or complementary procedure […]
Quidel-Ortho: A Merger of Contrasts
In 2021’s most notable IVD merger and acquisition, San-Diego, CA-based Quidel announced an acquisition of Raritan, N.J.-based Ortho Clinical Diagnostics. Both companies are in Kalorama’s IVD Market “Top Tier” And they couldn’t be more different. Quidel tends to sell to the clinic, Ortho Clinical to the hospital. Quidel sells flu and respiratory infectious disease tests, […]
19 Need-To-Know Developments in Cell and Gene Therapy
The following are recent developments in Cell and Gene Therapy, from Volume 1, Issue 13 of Cell and Gene Therapy Business Outlook, published December 22, 2021 Arrowhead Pharmaceuticals, based in Pasadena, CA, has completed a purchase of 13 acres in the Verona Technology Park in Verona, WI, where it plans to invest between $200 million […]
Long History of Disease Threats Boosts Blood Screening Market
From In Vitro Diagnostics Business Outlook Newsletter – Subscribe Today. Zika isn’t something covered in the news much anymore but in the blood screening IVD market, it still matters. So do all the other past disease threats to a pure blood supply, and the possible future threats. New disease threats reaching the level of concern […]